Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
6 hedge funds and large institutions have $103K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
32% more capital invested
Capital invested by funds: $78K → $103K (+$25K)
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7 |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$542 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $98K | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $5K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$542 | -15,300 | -47% |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| – | +$5 | +150 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| – | +$7 | +200 | +6% |
|
PHIOW Hedge Fund Activity: Q1 2019 in Review
6 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q1 2019, worth a combined $103K — up 32% from $78K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PHIOW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $7. The largest seller was Susquehanna International Group, cutting an estimated $542.
- 6 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q1 2019, up from 5 in Q4 2018.
- Funds reported $103K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q1 2019, up 32% quarter-over-quarter.
- 1 fund opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q1 2019 and 0 closed out, a net change of +1 holder.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q1 2019 was UBS Group, an estimated $7 added.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 seller in Q1 2019 was Susquehanna International Group, an estimated $542 sold.
Based on aggregated 13F filings for Q1 2019.